Position in VCEL
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$5,414,255
+$1,546,263 QoQ
Shares Held
121,696
+1.2% QoQ
Ownership
0.238%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#65
of 316 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VCEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Granite Investment Partners, LLC holds $85,167,773 across 14 Biotechnology names. VCEL ranks #6 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AXSM |
Axsome Therapeutics, Inc.
|
80,124 | $19,611,951 | |
| 2 | LGND |
Ligand Pharmaceuticals Inc
|
54,128 | $17,109,319 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
172,228 | $14,975,224 | |
| 4 | KRYS |
Krystal Biotech, Inc.
|
32,837 | $12,204,527 | |
| 5 | TECH |
BIO-TECHNE Corp
|
133,572 | $9,436,861 | |
| 6 | VCEL |
Vericel Corp
This page
|
121,696 | $5,414,255 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
63,598 | $4,977,815 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
5,026 | $398,511 |
All Filings in VCEL
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,414,255 | 121,696 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $3,867,992 | 120,236 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $2,599,201 | 72,180 | Shares | Sole | 2026-02-12 | |
| No filing history on record for this holder in this stock. | ||||||